From 97% Model Accuracy to 74% Clinical Reliability: Building RSN-NNSL-GATE-001

Disclaimer: The reliability calculations are illustrative heuristics assuming independent error rates, not empirical measurements. Real-world performance requires prospective validation as error correlation, workflow factors, and implementation context significantly affect outcomes. Examples discuss design considerations, not claims about specific products. This content is educational only and not medical, legal, or regulatory advice.

1️⃣The Challenge: Serial Reliability Degradation

Earlier this week, healthcare AI expert Claire Hast posted an observation that addresses important considerations in AI validation for healthcare. She walked through what may happen when a patient gets a mammogram:

Imaging device captures images (85-90% sensitivity range, FDA-regulated)

AI documentation tool generates clinical notes (accuracy ranges reported in literature: 70-95%, regulatory status varies by product and use case)

EMR system stores data—may not consistently distinguish between human-entered and AI-generated content

Diagnostic AI analyzes imaging + pulls clinical context from EMR (97% sensitivity, FDA-cleared)

Four systems. Each validated in isolation. When deployed as a serial pipeline, reliability may compound:

Important Note: This calculation represents a simplified heuristic model that assumes:

Independent error rates across components (which may not hold if errors are correlated)

Consistent measurement denominators (performance metrics may be measured on different populations/conditions)

Multiplicative error propagation (actual propagation may be more complex)

Real-world end-to-end reliability requires empirical validation in operational context, as factors like error correlation, data quality variation, workflow integration, and clinical decision-making processes can significantly impact actual performance.

💠Why This May Matter

According to a published review Claire cited, approximately 33 out of 950 FDA-cleared AI/ML devices included prospective real-world testing in their submissions. None were reported as tested as part of an interconnected clinical ecosystem [1].

EMR systems may not always tag which clinical history was entered by a physician versus generated by an AI tool. This creates a potential data provenance challenge: when diagnostic AI correlates imaging against clinical context:

High-accuracy model + unverified input quality = uncertain output reliability

This insight helped us frame a governance challenge we'd been exploring: how might one approach preventing potential reliability degradation in multi-stage AI pipelines?

2️⃣Our Approach: RSN-NNSL-GATE-001

We developed a fail-closed governance gate framework (RSN-NNSL-GATE-001) that attempts to evaluate clinical AI safety as a system property, not only a model property.

💠Design Principles

Based on Claire's framework, we explored seven guiding principles:

Human Dignity First: Patient safety prioritized over speed/cost considerations

End-to-End Assessment: Capture-to-decision reliability evaluation

Uncertainty Disclosure: Quantitative evidence when available

Fail-Closed Design: Unknown input triggers blocking rather than silent progression

Independent Auditability: External reproducibility where feasible

Traceable Accountability: Provenance chain documentation

Human Final Authority: AI as advisory, clinicians decide

💠The Reliability Model

We implemented the mathematical formula for serial system reliability:

💠Fail-Closed Defaults

This is the opposite of how most healthcare AI deploys. Current systems fail open—when something's wrong, they proceed anyway. We fail closed—we block and escalate to human review.

3️⃣Implementation Architecture

1. Governance Service Class

We extracted governance logic into a standalone service that:

a) Validates Evidence Completeness

b) Calculates End-to-End Reliability

c) Applies Gate Rules

2. Pipeline Integration

The governance gate plugs into the prediction pipeline as a certification stage:

3. Observer vs Enforce Mode

We deploy in stages:

Observer Mode (Phase 1):

Enforce Mode (Phase 2):

This lets us collect baseline metrics without disrupting workflows, then activate enforcement once we've validated thresholds.

4. Audit Trail Structure

Every gate evaluation emits a structured audit event:

This creates full reproducibility: given the same evidence and policy version, you can verify the gate decision.

4️⃣Real-World Impact: Preventing Data Quality Cascades

Senario:Preventing Data Qaulity Cascades

Let's walk through how this governance approach addresses Claire's observation:

Scenario: AI documentation tool generates clinical notes with unverified accuracy.

Without governance gates:

Generated data flows into EMR

Downstream diagnostic AI pulls it as clinical context

High-accuracy model processes potentially unreliable inputs

Clinician receives interpretation based on uncertain data

No visibility into input quality degradation

With RSN-NNSL-GATE-001:

Evidence collection identifies AI-generated content

transfer_integrity assessment flags unverified context quality

Gate calculation detects component below safety floor

Decision: BLOCK or CONDITIONAL (route to review)

Human oversight triggered before clinical interpretation

Audit trail documents the intervention and decision rationale

5️⃣What We Learned

1. Governance Must Be Executable, Not Aspirational

Most healthcare AI governance frameworks are PDFs with principles like "ensure quality" or "validate thoroughly." We needed something that could block a pipeline at runtime based on quantitative evidence.

Moving from policy documents to executable code forced precision:

What exactly is "adequate input quality"?

How do you measure "transfer integrity"?

What's the minimum acceptable p_e2e for clinical use?

2. The Weakest Link Is the Whole System

Even if aggregate reliability meets your threshold, if one component is critically unreliable, the system may be unsafe. Component-level floors are essential.

Example (illustrative):

p_capture = 0.95

p_transfer = 0.60 (documentation tool with quality concerns)

p_model = 0.97

p_clinical = 0.95

Aggregate: p_e2e ≈ 0.53 → Would trigger BLOCK

But even with a higher acceptance threshold, that low transfer quality should trigger review independent of the aggregate score—this is the "weakest link" principle in action.

3. Fail-Closed Is Harder But Necessary

Failing open is engineering-friendly: when in doubt, proceed. But in healthcare, "when in doubt" is exactly when you need human oversight.

Fail-closed requires:

Clear escalation paths for blocked cases

Clinician override protocols for time-sensitive decisions

Operational training on what gate decisions mean

Monitoring to prevent alert fatigue

4. Audit Trails Enable Learning

We retain audit events per policy requirements (multi-year retention for clinical accountability). This enables:

Identifying which components degrade most frequently

Calibrating thresholds based on real-world outcomes

Detecting systematic issues (e.g., specific model versions showing drift)

Responding to adverse events with full reconstruction of decision chain

6️⃣Final Thoughts

Claire Hast's insight about serial reliability degradation highlights a critical consideration in healthcare AI governance:

We validate components. We deploy systems.

The potential gap between component-level validation and integrated system performance is an important area for ongoing research and development.

The healthcare AI field would benefit from progress toward:

Component validation → ecosystem-level testing frameworks

Isolated performance claims → end-to-end reliability transparency

Fail-open defaults → fail-closed safety architectures where appropriate

The RSN-NNSL-GATE-001 framework represents our approach to this challenge. It's not a complete solution, but it's executable, auditable, and grounded in reliability engineering principles.

If you're building healthcare AI systems, consider:

What's your end-to-end reliability model?

How do you measure and validate each component?

What happens when a component's quality is uncertain?

Do you fail open or fail closed, and why?

7️⃣Resources

[1] Systematic review discussed in this article: JAMA Network Open, 2025 (device submission analysis): Link

Claire Hast's LinkedIn post on healthcare AI validation: Link

What governance frameworks are you exploring for healthcare AI? How do you approach end-to-end reliability assessment?